Delving into the Latest Updates on Beijing Innovic Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Other Diseases

Congenital Disorders

Nervous System Diseases

AAV based gene therapy

miRNA

Fusion protein

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	6
Endocrinology and Metabolic Disease	3
Neoplasms	1

Top 5 Drug Type	Count

AAV based gene therapy	11
miRNA	2
Fusion protein	1

Top 5 Target	Count

RDH12(retinol dehydrogenase 12)	1
SOD1(Superoxide dismutase)	1
ABCA4(ATP binding cassette subfamily A member 4)	1
OPN3(opsin 3)	1
FGF21(Fibroblast growth factor 21)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Nov 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

7

4

Preclinical

Early Phase 1

2

1

Phase 2

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

IVB-103	Wet age-related macular degeneration More	Phase 1/2
IVB-107 ( RDH12 )	Retinitis Pigmentosa More	Early Phase 1
IVB-102 ( XLRS1 )	Retinoschisis More	Early Phase 1
IVB-105 ( OPN3 )	Retinitis Pigmentosa More	Preclinical
IVB-108	Geographic Atrophy More	Preclinical